[Development and clinical approval of a micromodification of the human leukocyte migration inhibition reaction].
The author suggests a new modification of the human blood leukocyte migration inhibition test. The results of the clinical approval of the test permit it to be recommended for the investigation in dynamics of the cellular immunity and the humoral factors in ptients with different immunopathological state. This modification permits to carry out 10-15 parallel investigations using small quantitites of the blood.
D000328:Adult; D000906:Antibodies / Q000032:analysis; D001172:Arthritis, Rheumatoid / Q000276:immunology; D001859:Bone Neoplasms / Q000276:immunology; D002464:Cell Migration Inhibition; D002648:Child; D002986:Clinical Trials as Topic; D004342:Drug Hypersensitivity / Q000276:immunology; D006801:Humans; D007111:Immunity, Cellular; D007158:Immunologic Techniques; D007962:Leukocytes / Q000276:immunology*
D000906:Antibodies
Razrabotka i klinicheskaia aprobatsiia mikromodifikatsii reaktsii tormozheniia migratsii leĭkotsitov krovi cheloveka